NICE guidance on pembrolizumab for advanced melanoma.
暂无分享,去创建一个
I. Watson | E. J. Adam | E. Donegan | Z. Charles | Janet Robertson | Pilar Pinilla Dominguez | Janet E. Robertson | Pilar Pinilla Dominguez | E Jane Adam
[1] J. Larkin,et al. Pembrolizumab versus Ipilimumab in Advanced Melanoma. , 2015, The New England journal of medicine.